GulfBase Live Support
Leave a message and our representative will contact you soon
24/12/2017 06:18 AST
National Pharmaceutical Industries Company plans to raise its capital by OMR5 million by way of a rights issue. The company has received approval from the Capital Market Authority (CMA) for the rights issue and accordingly, 50 million shares will be issued to the existing shareholders at a price of 102 baisas per share.
The board of directors of the company approved a proposal to raise of the company's capital from OMR5 million to OMR10 million.
The CMA approved the rights issue prospectus based on the request of the company's management and in compliance with all the requirements of the issue.
Times of Oman
| Ticker | Price | Volume |
|---|
06/03/2026
Emirates NBD has waived a range of banking fees for customers across the UAE and the wider Gulf, making cash and card services easier to access during a period of heightened regional uncertainty.
Gulfnews
06/03/2026
2PointZero Group, a next-generation investment powerhouse focused on energy and consumer sectors, has announced that it has formally completed the transaction to acquire a majority position in ISEM,
Trade Arabia
06/03/2026
SAL Saudi Logistics Services Co. has agreed to acquire Belgium-based Aviapartner Liege SA for ?28 million ($30.3 million), giving the Saudi logistics firm a foothold at one of Europe's major air carg
Arab News
06/03/2026
Saudi mining and metals company Maaden has reported a 156 percent jump in its net profit attributable to shareholders for 2025, driven by higher commodity prices, record production volumes, and a one
Arab News
05/03/2026
The Oman Oil Marketing Company (OOMCO) has formally announced that one of its fuel storage tanks on March 3 the subject of an incident. In a statement released on March 4, the company confirmed that
Muscat Daily